industry
November 16, 20266 min readDRMED Quality & Compliance

Technical Files vs Design Dossiers Under EU MDR

Anyone who has sat through a supplier audit or a regulatory conversation about the EU Medical Device Regulation (MDR) has likely heard both "technical file" and "design dossier" used, sometimes interchangeably, sometimes as if they mean very different things. Neither term is formally defined in the MDR text itself, which is part of why the usage is inconsistent. Understanding where the terms come from and what they map to under the current regulation helps distributors and procurement teams ask sharper questions when they review a manufacturer's documentation set.

Where the Two Terms Come From

The vocabulary is a holdover from the MDR's predecessor, the Medical Device Directive (MDD). Under MDD, lower-risk devices were typically documented in a technical file reviewed as part of a manufacturer's quality system audit, while higher-risk Class III and certain implantable devices required a design dossier: a more extensive, device-specific submission examined directly by a notified body before the device could carry a CE mark. That split, technical file for most devices versus a dedicated per-device design examination for the highest-risk category, is the origin of the two terms many people in the industry still reach for.

What MDR Actually Requires: Annex II and Annex III

MDR replaced that split with a more unified concept called technical documentation, structured primarily under Annex II and Annex III. Annex II sets out the general content expected for every device: device description and intended purpose, design and manufacturing information, general safety and performance requirements, risk management documentation, and verification and validation data. Annex III adds the post-market surveillance documentation that must accompany it, including the post-market surveillance plan and, where applicable, the periodic safety update report. In MDR's own language, there is no separate "technical file" versus "design dossier" category; there is one technical documentation structure that scales in depth with the device's classification and risk profile.

Why "Design Dossier" Still Comes Up in Conversation

Even though MDR does not use the term formally, the underlying idea of deeper, device-specific scrutiny for higher-risk devices persists. Class III devices and certain implantable or long-term devices are still subject to more extensive notified body involvement, including a clinical evaluation consultation procedure (sometimes called the scrutiny mechanism) for a defined subset of high-risk categories. In practice, many manufacturers, notified bodies and quality teams continue to use "design dossier" informally to describe the fuller, device-specific documentation bundle assembled for these higher-scrutiny categories, even though the formal regulatory label is simply technical documentation under Annex II and III.

What This Means When Reviewing a Supplier's Documentation

For a distributor or institutional buyer, the practical takeaway is to focus on content rather than labels:

  • Ask what Annex II elements are actually present: intended purpose, risk management file, verification and validation summaries, and labeling, rather than whether the supplier calls it a "file" or a "dossier."
  • Check whether Annex III post-market surveillance documentation is current, since this is where real-world performance data and any periodic safety updates should appear.
  • For higher-risk device categories, ask about notified body involvement directly, including whether any additional clinical evaluation consultation applied, rather than relying on terminology alone to judge scrutiny level.
  • Keep in mind that terminology varies by manufacturer and by which regulation (MDD-era legacy devices versus MDR) governs a given product, since some suppliers are still transitioning older documentation sets.

The Takeaway

"Technical file" and "design dossier" are useful shorthand that predates MDR and still circulates because the underlying idea, that risk level drives documentation depth and regulatory scrutiny, remains true today. What changed is the formal structure: a single technical documentation framework under Annex II and III that scales with classification, rather than two distinct submission types. For buyers, the safer habit is to ask what specific documentation elements a supplier can produce and how current they are, rather than which of the two legacy terms the supplier happens to use.

This is general educational information, not legal or regulatory advice; consult the current official texts and your competent authority.